Nasdaq · Healthcare

Outset Medical, Inc. (OM)

As-reported financials and recent SEC filings for Outset Medical, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$119.5M

Net income

$-81.7M

Net margin

-68.3%

Diluted EPS

$-5.37

ROE

-64.3%

P/E (TTM)

—

Market cap

—

Debt / equity

0.8×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$119.5M	$113.7M	$130.4M	$115.4M	$102.6M
Gross profit	$46.8M	$38.6M	$29.0M	$17.8M	$7.6M
Operating income	$-66.7M	$-113.4M	$-169.8M	$-161.0M	$-130.5M
Net income	$-81.7M	$-128.0M	$-172.8M	$-163.0M	$-131.9M
Diluted EPS	$-5.37	$-9.24	$-13.07	$-12.67	$-10.84

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-29

42026-06-29

42026-06-29

8-K2026-06-17

42026-06-05

42026-06-05

42026-06-05

42026-06-05

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on OM

Search Outset Medical, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.